Bayer mulls bid for Pfizer's vet unit

Bayer CEO Marijn Dekkers says he's taking a look at bidding on Pfizer's ($PFE) animal health unit if the company decides to put it up for auction. The company is most interested in "smaller" deals right now; the Pfizer unit could bring as much as $16 billion. Report

Suggested Articles

Merck's Keytruda has new long-term survival results that the drugmaker hopes will help bolster its position in first-line NSCLC.

Last year at ESMO, AZ and Merck showed Lynparza topped its rivals at fending off prostate cancer. Now, Lynparza has helped patients live longer, too.

Merck and Eisai are trying to take their Keytruda-Lenvima combo into additional cancers, and new data provide a glimpse of where it might go next.